Medical Ozone Therapy in Greenville, SC
Medical Ozone Therapy at IHP Greenville. Dr. Hendry, DAOM — functional medicine, root-cause diagnostics, personalized care. Call (864) 365-6156.
"I have to say that finding this clinic was a true miracle. At the beginning of 2019 I got to the low point of my health and landed in the ER. Medical doctors told me I just had a GI issue and should just take some meds for it. Dr. Hendry changed everything for me."
— Tat V. · April 2020 · Google Review
Medical ozone is not ozone pollution. Environmental ozone at ambient concentrations is a lung irritant — medical ozone is administered through the gut, skin, or joint space, never inhaled, at precisely measured concentrations that produce a sub-cytotoxic oxidative signal. That signal is Bocci's oxidative preconditioning mechanism: the ozone reacts with polyunsaturated fatty acids to generate hydrogen peroxide and lipid oxidation products that activate Nrf2 and suppress NF-kB-driven inflammatory gene expression. The antiviral effect is documented — ozone disrupts microbial membrane phospholipids and viral envelope glycoproteins through a mechanism that doesn't generate the selective pressure for resistance that antibiotics do. My AAOT training determines which route, which concentration, and which volume is appropriate for the specific clinical indication.
How Medical Ozone Therapy Works
Medical ozone therapy at IHP is available via rectal insufflation (most systemic route), ear and nasal insufflation (upper respiratory and neurological conditions), ozone sauna (transdermal systemic delivery), and localized applications for wounds or joint conditions. All ozone is generated fresh from medical-grade oxygen immediately before use — ozone cannot be stored. Concentrations and volumes are precisely measured and recorded for each session.
Conditions Treated with Medical Ozone Therapy
Medical Ozone vs. Antibiotic Therapy for Chronic Low-Grade Infections
Antibiotic therapy remains the standard of care for acute bacterial infections and is clinically essential in that context. However, for chronic low-grade infections — biofilm-associated organisms, intracellular pathogens such as Borrelia burgdorferi, or recurrent fungal dysbiosis — antibiotics face two fundamental limitations: biofilm resistance and disruption of commensal microbiome architecture. A patient presenting with six months of recurrent sinusitis, low-grade fever, and elevated C-reactive protein despite multiple antibiotic courses illustrates the clinical gap. Biofilm-embedded organisms can demonstrate 1,000-fold increased antibiotic resistance relative to planktonic forms, rendering standard dosing clinically ineffective. Medical ozone operates through a distinct mechanism: O3-derived peroxides penetrate biofilm matrices because lipid oxidation disrupts the polysaccharide biofilm scaffold rather than targeting a specific microbial enzyme — making resistance development mechanistically unlikely (Bocci, 2011). Simultaneously, ozone's NF-kB suppression reduces the chronic inflammatory milieu that sustains infection persistence. Unlike broad-spectrum antibiotics, ozone does not suppress Lactobacillus or Bifidobacterium populations, preserving the intestinal barrier that prevents secondary opportunistic infections. These are not equivalent therapies competing for the same indication — they address fundamentally different clinical scenarios within the spectrum of infectious disease management.
Research & Evidence
Medical ozone (O3) is a triatomic oxygen allotrope that, at controlled concentrations between 10 and 80 micrograms per milliliter, initiates a cascade of well-characterized biochemical events without cellular cytotoxicity. Upon contact with biological fluids, O3 reacts with polyunsaturated fatty acids to generate hydrogen peroxide (H2O2) and lipid oxidation products that serve as second messengers, activating the nuclear factor Nrf2 and suppressing NF-kB-mediated pro-inflammatory gene transcription. Bocci V. (Ozone: A New Medical Drug, Springer, 2011) described this mechanism as oxidative preconditioning: a hormetic oxidative signal that upregulates superoxide dismutase, catalase, and glutathione peroxidase while reducing inflammatory cytokine expression. In the context of intervertebral disc pathology, Andreula CF et al. (AJNR Am J Neuroradiol, 2003) demonstrated that intradiscal oxygen-ozone injection reduced nucleus pulposus volume through proteoglycan oxidation, directly decompressing the nerve root, while simultaneously reducing prostaglandin-mediated nociceptive signaling in the periradicular tissue. Elvis and Ekta (J Nat Sci Biol Med, 2011) further documented ozone's anti-infective properties through disruption of microbial cell membrane phospholipids and inhibition of viral envelope glycoproteins — mechanisms operative across bacterial, fungal, and viral pathogens.
Your First Appointment
G6PD deficiency testing is recommended before beginning ozone therapy (G6PD deficiency is an absolute contraindication). Hyperthyroidism is also a contraindication. Dr. Hendry reviews your complete health history and current medications before first treatment.
Why Dr. Hendry for Medical Ozone Therapy
Dr. Hendry's AAOT membership represents formal professional training in medical ozone therapy protocols, safety, and clinical indications — ensuring that ozone at IHP is used at evidence-based concentrations for appropriate conditions.